I find it concerning that BRN continues to emphasize a COVID19 breathalyzer as the first commercial breakthrough application at the same time as massive amounts of vaccines are manufactured every day, and mass testing becomes available for very little cost in various places, meaning that in a few weeks life will pretty much return to normal and there will be no meaningful economics to such a product.
Even if the product was available today - which it is not - I am doubtful about its economic viability.
BRN should focus on areas where it can make a real difference, with solutions others cannot offer (yet).
Less podcasts, more tangible commercial successes.
2021 BRN Discussion, page-371
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $563.0M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.0¢ | 30.0¢ | $2.997M | 9.764M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 245232 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 10754 | 1 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
30.0¢ |
Change
-0.010 ( 4.88 %) |
||||
| Open | High | Low | Volume | ||
| 31.5¢ | 32.0¢ | 30.0¢ | 5406233 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| BRN (ASX) Chart |